Journal of Clinical Trials : Citations & Metrics Report
Articles published in Journal of Clinical Trials have been cited by esteemed scholars and scientists all around the world. Journal of Clinical Trials has got h-index 22, which means every article in Journal of Clinical Trials has got 22 average citations.
Following are the list of articles that have cited the articles published in Journal of Clinical Trials.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
64 | 66 | 79 | 78 | 38 | 20 | 35 | 52 | 44 | 54 | 25 | 31 | 3 |
Research, Review articles and Editorials |
27 | 33 | 67 | 44 | 22 | 11 | 20 | 39 | 41 | 47 | 19 | 27 | 3 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
37 | 33 | 12 | 34 | 16 | 9 | 15 | 13 | 3 | 7 | 6 | 4 | 0 |
Conference proceedings |
0 | 5 | 12 | 0 | 15 | 115 | 118 | 56 | 63 | 0 | 0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
175 | 190 | 167 | 179 | 137 | 137 | 143 | 0 | 0 | 0 | 0 | 0 | 0 |
| Journal total citations count | 1734 |
| Journal impact factor | 2.76 |
| Journal 5 years impact factor | 3.07 |
| Journal cite score | 3.14 |
| Journal h-index | 22 |
| Journal h-index since 2019 | 16 |
Important citations (609)
India is the clinical trials hub for some pharm companies of developed nations [1-10]. we are a nation with a vast pool of heterogeneous patients, substantial number of restorative ability with english tongue, expanding rates of clinics with great foundation and therapeutic supplies. the expense of clinical trial is reduced up to 60% when compared to that of developed nations. notwithstanding that we have got some great administrative power set up in our nation [11-20]. focal central drug standard control organization (cdsco) regulates the clinical trial process in india through, icmr and indian gcp. these trials directed in india are guaranteed and sanction by universal rules and regulations, as, ich and fda under strict review of irb/iec. clinical trials in india had a look from cdisc because of its fast growth in the trials. although these facilities seem to be enough for the establishment of more trials the limitations cease from the development. in this article we will discuss such limitations [21-30]. |
|
Interventions for schizophrenia----- an emerging mental disorder |
|
Clinical trial participation in india |
|
clinical trial participation in india |
|
Clinical trial participation in india |
|
Clinical trial participation in india |
|
Mechanism of changes balance anaerobic processes and aerobic processes in cancer metabolism causing warburg effect mechanism |
|
Sars-cov-2 affected cells pathogeny and therapy |
|
Clinical trial participation in india |
|
Clinical trial participation in india |
|
The opioid epidemic: task-shifting in health care and the case for access to harm reduction for people who use drugs. |
|
The impact of employment on recovery among individuals who are homeless with severe mental illness in the vancouver at home/chez soi trial |
|
Exploring the relationship between neighbourhood quality (nq) and housing stability among formerly homeless individuals with mental illness in housing first |
|
Clinical trial participation in india |
|
A review of persistent idiopathic dentoalveolar pain (formerly pdap/atypical odontalgia) |
|
An injectable heparin-conjugated hyaluronan scaffold for local delivery of transforming growth factor ?1 promotes successful chondrogenesis. |
|
An injectable heparin-conjugated hyaluronan scaffold for local delivery of transforming growth factor ?1 promotes successful chondrogenesis. |
|
Decellularized tissue engineered hyaline cartilage graft for articular cartilage repair |
|
Effects of obesity on liver cytochromes p450 in various animal models |
|
The future of genomic testing in primary care: the changing face of personalized medicine |
|